Operating Expenses
Pfizer·Income Statement·4 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Selling, general and administrative | $3.7B | $3.2B | $4.3B | $3B | $3.4B | $3.2B | $4.2B | $3B |
| Depreciation and amortization | $1.3B | $1.3B | $1.4B | $1.2B | $1.2B | $1.2B | $1.2B | $1.6B |
| Amortization of Intangible Assets (Unallocated) | $1.3B | $1.3B | $1.4B | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Restructuring charges and certain acquisition-related costs | $1.3B | $313M | $750M | $678M | -$18M | $286M | $605M | $100M |